Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Eosinophilic Esophagitis (EoE) in Children as Young as 1 Year Old

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. ACN
2. SPCX
3. NVDA
4. MSTR
5. MU
6. DFTX
7. BAUFF
8. ICE
9. KR
10. RGA

Go back to Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Eosinophilic Esophagitis (EoE) in Children as Young as 1 Year Old
Regeneron (NASDAQ: REGN) Delayed: 609.94 --0 (-0%)
Previous Close $609.94    52 Week High $592.36 
Open $609.94    52 Week Low $325.35 
Day High $609.94    P/E 160.09 
Day Low $609.94    EPS $3.81 
Volume 6,055       

Regeneron (NASDAQ: REGN) Delayed: 609.94 --0 (-0%)
Previous Close $609.94    52 Week High $592.36 
Open $609.94    52 Week Low $325.35 
Day High $609.94    P/E 160.09 
Day Low $609.94    EPS $3.81 
Volume 6,055